Sharing-our-perspective




Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • FDA approves first generic of Advair Diskus® inhaler for asthma and COPD

    by
    • Optum for Workers' Compensation
    | Feb 05, 2019
    Tag Icon
    Generics, FDA, FDA approved, Pharmacy, workers compensation, Clinical
    After almost 20 years on the market as a name-brand medication, the FDA has approved the first generic version of Advair Diskus inhaler for asthma and COPD. See availability, timing, dosing and relevance to work comp on our blog.


  • New York revises drug formulary proposal and releases updated medication list

    by
    • Optum Workers Comp
    | Jan 28, 2019
    Tag Icon
    workers compensation, Government Affairs, Drug Formulary
    The New York Workers’ Compensation Board (WCB) has released a third proposed rule version of the drug formulary and an updated drug list. This action follows the WCB’s review of submitted comments, as well as continued collaboration with stakeholders.


  • Register for 2019 Continuing Education

    by
    • Optum Workers' Comp
    | Jan 25, 2019
    Tag Icon
    Government Affairs, Webinar - Workers' Compensation, workers compensation, Settlement, Pharmacy, Pain Management, Clinical, Continuing Education
    From the state house, to the pharmacy, to claim resolution, Optum is kicking off its 2019 continuing education calendar with "What to watch for in 2019." See our full year of topics & register to gain the knowledge you need to move move forward this year!


  • FDA creates faster way to access over-the-counter naloxone products to treat opioid overdoses

    by
    • Optum for Workers' Compensation
    | Jan 24, 2019
    Tag Icon
    Opioids, FDA, Clinical
    The U.S. Food and Drug Administration (FDA) recently established a more rapid path for pharmaceutical companies to add over-the-counter (OTC) naloxone products to the market to increase access to naloxone – a life-saving medication used for the emergency treatment of opioid-related overdose – and help reduce opioid-related overdose deaths.


  • The latest on new medications, generics, recalls and safety communications

    by
    • Optum Workers' Comp
    | Jan 17, 2019
    Tag Icon
    safety communications, recall, Generics, Clinical
    In this edition of the Clinical Info Newsletter, we examine several new medications for pain management including an opioid analgesic and non-opioid treatments.



Stay informed by receiving latest updates

Do you have a question about a blog post?